Shumin Li

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Replacement Therapy

Top Venues

EMBO molecular medicine

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Xiao-Wen Yu, Man Xu, Xia Meng, Shumin Li, Qian-Qi Liu, Mi Bai, Ran You, Songming Huang, Li Yang, Yue Zhang, Zhanjun Jia, Aihua Zhang
Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI. Science translational medicine 12 (543) (2021)